Efloxate

● Article ● Talk ● Language ● Watch ● Edit

This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Efloxate" – news · newspapers · books · scholar · JSTOR (February 2022) (Learn how and when to remove this message)

Efloxate is a vasodilator.^[1]

Efloxate
Clinical data

ATC code	C01DX13 (WHO)
Identifiers
IUPAC name ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate
CAS Number	119-41-5^Y
PubChem CID	8395
ChemSpider	8089
UNII	CZU6V3902K
ChEMBL	ChEMBL1349073
CompTox Dashboard (EPA)	DTXSID3048736
ECHA InfoCard	100.003.929
Chemical and physical data
Formula	C₁₉H₁₆O₅
Molar mass	324.332 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3
InChI InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3 Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N
(verify)

References

^ Tomasi AM, Masoni A (August 1977). "[Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris]". La Clinica Terapeutica (in Italian). 82 (3): 227–41. PMID 334448.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Efloxate&oldid=1136147892" Last edited on 28 January 2023, at 23:56

●This page was last edited on 28 January 2023, at 23:56 (UTC). ●Content is available under CC BY-SA 4.0 unless otherwise noted. ●Privacy policy ●About Wikipedia ●Disclaimers ●Contact Wikipedia ●Code of Conduct ●Developers ●Statistics ●Cookie statement ●Terms of Use ●Desktop